Lupin acquires US generics firm GAVIS for $880 mn

  Deal marks the largest acquisition by an Indian pharma company in the US In its fifth foreign acquisition within 18 months, Lupin on Thursday said it would acquire New Jersey-based generic......

Drugs of 7 Indian pharma firms in EMA's suspension list

Several drugs manufactured and marketed by as many as seven Indian generic pharmaceutical companies have been recommended for suspension by the European Medicines Agency (EMA) in its orders issued......

Big pharma disappoints, but growth on track

The Street is unimpressed by the results of the top three pharma companies, but given the share price correction and earnings outlook, there are gains to be made.India's largest pharma companies by......

Integration key to Sun-Taro deal

Sun Pharma's acquisition of Taro, the Israeli drug company, after a three-year legal battle, will now be followed by a much longer struggle to see a successful integration of the two businesses,......